Considering that Eag1 is also associated with malignant transformation and other hyperproliferative disorders such as cervical cancer [47], our results highlight Eag1 as a potential clinical oncogenic target as shown in this study with calcitriol in combination with astemizole. The gene discussed is KCNH1; the disease is cervical carcinoma.